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Abstract 
Background: Experimentally, lung inflammation in laboratory animals is usually detected by the presence of inflam-
matory markers, such as immune cells and cytokines, in the bronchoalveolar lavage fluid (BALF) of sacrificed animals. 
This method, although extensively used, is time, money and animal life consuming, especially when applied to genet-
ically modified animals. Thus a new and more convenient approach, based on in vivo imaging analysis, has been set 
up to evaluate the inflammatory response in the lung of CFTR-deficient (CF) mice, a murine model of cystic fibrosis.
Methods: Wild type (WT) and CF mice were stimulated with P. aeruginosa LPS, TNF-alpha and culture supernatant 
derived from P. aeruginosa (strain VR1). Lung inflammation was detected by measuring bioluminescence in vivo in 
mice transiently transgenized with a luciferase reporter gene under the control of a bovine IL-8 gene promoter.
Results: Differences in bioluminescence (BLI) signal were revealed by comparing the two types of mice after intratra-
cheal challenge with pro-inflammatory stimuli. BLI increased at 4 h after stimulation with TNF-alpha and at 24 h after 
administration of LPS and VR1 supernatant in CF mice with respect to untreated animals. The BLI signal was signifi-
cantly more intense and lasted for longer times in CF animals when compared to WT mice. Analysis of BALF markers: 
leukocytes, cytokines and histology revealed no significant differences between CF and WT mice.
Conclusions: In vivo gene delivery technology and non-invasive bioluminescent imaging has been successfully 
adapted to CFTR-deficient mice. Activation of bIL-8 transgene promoter can be monitored by non-invasive BLI imag-
ing in the lung of the same animal and compared longitudinally in both CF or WT mice, after challenge with pro-
inflammatory stimuli. The combination of these technologies and the use of CF mice offer the unique opportunity of 
evaluating the impact of therapies aimed to control inflammation in a CF background.
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Background
In cystic fibrosis (CF), chronic neutrophilic inflamma-
tion with the release of damaging neutrophil products, 
such as neutrophil elastase, constitutes a key risk factor 
in early structural lung damage and lung function decline 
[1]. Bacterial infection stimulates an intense neutrophilic 
response which fails to eradicate the infection leading to 
sustained release of pro-inflammatory mediators, con-
tinuous influx of inflammatory cells and bacteria persis-
tence [2]. Despite advances in our understanding of the 
molecular and cellular basis of CF, the paradox of why 
recruited neutrophils fail to eradicate bacterial infections 
in the lung remains [2, 3], although recent data from our 
group indicate a deficit in leukocyte trafficking as a pos-
sible mechanism [4]. The progress in understanding the 
relationship between cystic fibrosis airway inflammation 
and infection may facilitate the understanding on how to 
interrupt the self-perpetuating inflammatory response 
and pursue new directions in treatment.
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Measuring airway inflammation in CF is important for 
initiating the anti-inflammatory treatment and monitor-
ing its effect. At present, no inflammatory biomarker has 
been consistently shown to predict clinical efficacy [3]. 
Frequently, in mouse models, inflammation is induced by 
instillation of bacterial products with pro-inflammatory 
activity such as lipopolysaccharide (LPS) and monitored 
by analyzing the presence of inflammatory markers. 
Unfortunately, the conventional assessments of inflam-
mation in mice often rely on invasive ex  vivo measure-
ments which causes the death of the animal and are 
consequently particularly onerous when costly transgenic 
mice are utilized. Moreover, this protocol may not be 
fully reproducible, probably due to the heterogeneity of 
airway inflammation in CF. Furthermore, the characteri-
zation of pulmonary functions, cellular infiltration and 
cytokines determination in BALF and the observation of 
anatomical changes, such as airway remodeling due to 
inflammation, an approach that, while extensively used 
and highly validated, precludes the possibility to repeat 
longitudinally the assessment of test animals [5–7]. How-
ever, in vitro and in vivo protocols in animal models have 
been used to study the mechanism of lung inflammation 
in chronic diseases and to evaluate the anti-inflamma-
tory role of some candidate molecules [8–10]. Recently 
emerging non-invasive imaging technologies such as 
magnetic resonance imaging (MRI), micro-CT and opti-
cal imaging have been applied to longitudinal monitoring 
of airway remodeling and inflammation in murine mod-
els [11–14]. The clinical imaging system used in MRI, CT 
and PET, have been further adapted to murine models of 
asthma [11, 15–17], to serve as a preclinical and trans-
lational step between basic discovery and clinical prac-
tice, whereas optical imaging technologies developed in 
experimental settings may also slow-down their way into 
the clinical practice, especially in the context of intraop-
erative activities [18, 19]. Recently a mouse model tran-
siently expressing the luciferase reporter gene under the 
control of a bovine IL-8 promoter has been generated 
[20]. Although mice do not express IL-8, the cell signal-
ing and transcriptional apparatus could specifically acti-
vate the bovine IL-8 promoter [20]. In the present work, 
real time monitoring of lung inflammation in CF mice 
has been successfully applied by taking advantages of the 
genetic construct carrying the IL-8 promoter/luciferase 
reporter gene.
Methods
Experimental animals
Gut-corrected CFTR-deficient female C57Bl/6 Cftrtm1-
UNCTgN(FABPCFTR)#Jaw and their congenic WT 
female mice, 6–8 weeks old (Charles River), provided by 
the (CFaCore facility, Milano, Italy), were used. Prior to 
use, animals were acclimatized for at least 5 days to the 
local vivarium conditions (room temperature: 20–24 °C; 
relative humidity: 40–70  %; 12-h light–dark cycle), hav-
ing free access to standard rodent chow and softened 
tap water. All animal experiments described herein 
were approved by the intramural animal-welfare com-
mittee for animal experimentation of Chiesi Farmaceu-
tici and by the Interdeparmental Centre of Experimental 
Research Service at the University of Verona, and comply 
with the European Directive 2010/63 UE, Italian D.Lgs 
26/2014 and the revised “Guide for the Care and Use of 
Laboratory Animals”.
Collection of bacterial cell‑free supernatants
P. aeruginosa strain, VR1 was isolated from a sputum 
sample of a CF patient followed at the Cystic Fibrosis 
Center in Verona, Italy. Written informed consent was 
obtained from the subjects enrolled in the study and 
approved by the Institutional Review Board of Azienda 
Ospedaliera Universitaria Integrata (AOUI) Verona as 
project 1612. The bacterial strain was grown overnight at 
37  °C in Bacto™ Tryptic Soy Broth (TSB, Becton, Dick-
inson and Company) with continuous agitation. The day 
after, P. aeruginosa cells were diluted in TSB to the con-
centration of 1 × 108 CFU/ml (OD of 0.1 at 600 nm) and 
grown overnight at 37 °C shaking. The following day, the 
culture was normalized to an optical density of 0.2 OD 
at 600  nm. Culture supernatant (VR1Sn) was collected 
by centrifugation (7000×g, 30  min, 4  °C) and filtered 
through a 0.22 µm Millipore filter to remove any remain-
ing bacteria. VR1Sn was concentrated to 30× using 
Amicon Ultra-15 30  K (Millipore, Billerica, USA), then 
centrifuged at 27,000×g for 1 h at 4 °C to remove cellular 
debris and finally sterilized by filtration through a Milli-
pore 0.22 µm filter.
In vivo gene delivery
The bIL-8-Luc plasmid (Dipartimento di Scienze Medico 
Veterinarie, Università di Parma, Italy) was obtained by 
sub-cloning the 2030  bp IL8 bovine promoter, ampli-
fied by PCR from Madin–Darby bovine kidney (MDBK; 
ATCC #CCL-22) genomic DNA into the digested pGL-
3basic vector (promega) as previously described [20]. We 
applied in vivo JetPEI (Polyplus Transfection) as a carrier 
for delivering DNA to lung tissues. The DNA and JetPEI 
mix was formulated according to the product manual 
with a final N/P ratio of 7.5. Briefly, 50 μg of bIL-8–Luc 
and 7.5 μL of JetPEI were both diluted into 200 μL 5 % 
glucose. The two solutions were then mixed and incu-
bated for 15 min at room temperature. The entire mixture 
was injected intravenously in mice and the expression of 
bIL-8–Luc was monitored through imaging with IVIS 
Spectrum (Perkin Elmer, Massachusetts, USA).
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In vivo bioluminescence imaging
Transfection per se causes a mild lung inflammatory 
response and bIL-8 activation, which is detectable by 
BLI up to 3–4  days after DNA injection and disappears 
completely after 1 week [20, 21]. No difference in exten-
sion and duration of BLI signal between wild type and CF 
mice at 3–4 and 7 days of observation after DNA deliv-
ery has been observed. (Additional file 1: Figure S1). One 
week after DNA delivery, before initiating the experi-
ment, all the transient transgenic mice were injected 
intraperitoneally (i.p.) with luciferin (150  mg/kg) and 
BLI was recorded in order to check the baseline activa-
tion of the IL-8 pathway. Slightly differences in promoter 
activation detected in the different mice can be normal-
ized by dividing the BLI value obtained from each mouse 
with the basal photon emission found in the same mouse 
in order to determine the fold of induction (FOI) as pre-
sented in the graphs. This procedure ensures that the 
data are referred to each individual animal and take in 
account even slightly different response rates.
Briefly, 10 and 15  min after luciferin injection, mice 
were lightly anesthetized with isoflurane and images were 
obtained using the IVIS imaging system: a total of pho-
tons emitted from the chest of the mice was quantified 
using Living Image ® software (Perkin Elmer Inc. Boston, 
MA, USA).
The following day, mice were intratracheally challenged 
with P. aeruginosa LPS (6.125  µg/mouse), VR1Sn (10×) 
or human TNF-alpha (1  µg/mouse) using a volume of 
50 μl and BLI was recorded at 4, 24, and 48 h. Data were 
expressed as mean folds of induction (FOI) over the base-
line activation of each mouse.
Bronchoalveolar lavage and cytokines
Twenty-four hours after intratracheal challenge, animals 
were weighted, anaesthetized with isoflurane and sac-
rificed by bleeding from the abdominal aorta for bron-
choalveolar lavage fluid (BALF) collection, performed as 
previously described [20]. BALF supernatants were fro-
zen at −80  °C for simultaneous quantification of multi-
ple cytokines/chemokines using a Bio-Plex™ Cytokine 
Assay Kit (Bio-Rad Laboratories, Segrate, Milan, Italy). 
The cell pellet was resuspended in 0.2 mL of phosphate 
buffered saline (PBS) and total and differential cell counts 
were obtained using an automated cell counter (Dasit XT 
1800 J, Cornaredo; Milan, Italy).
Histology
Lungs were removed and inflated with a cannula through 
the trachea by gentle infusion with 0.6 ml of 10 % neu-
tral-buffered formalin. Subsequently, the lungs were 
placed in 10 % formalin and fixed for at least 24 h. The 
whole lungs were dehydratated in graded ethanol series, 
clarified in xylene and paraffin embedded. 5  μm thick 
sections were cut with a rotary microtome (Reichert–
Jung 1150/Autocut) in ventral dorsal plane. For analysis, 
the sections were stained with hematoxylin-eosin and 
Giemsa according to standard methods. A previously 
described lung injury score [22], that included the evalu-
ation of neutrophils in the alveolar and in the interstitial 
space, the formation of hyaline membranes, the presence 
of proteinaceus debris and the alveolar septal thickening 
was applied.
Reagents
In vivo JetPEI DNA transfection reagent (polyplus trans-
fection) was obtained from Euroclone (Milan, Italy), 
D-luciferin was obtained from Perkin Elmer Inc. (Boston, 
MA, USA). LPS (from P. aeruginosa 0111:B4, product 
n.L3012) from Sigma (St. Louis, MO) was resuspended in 
Eagle’s minimal essential medium (EMEM).
Data analysis
Experimental values were expressed as the mean and 
standard error of the mean (SEM). Statistical analysis was 
performed using one-way analysis of variance followed 
by Dunnett’s t test (*p < 0.05, **p < 0.01).
Results
The possibility to monitor longitudinally in no-invasive 
way the activation of IL-8 in the same mice CF compared 
to WT after intratracheally challenged with inflamma-
tory stimuli such as: human TNF-alpha, LPS P. aerugino-
sis and with the culture supernatant obtained from the P. 
aeruginosa clinical strain VR1 is step a forward in inves-
tigating the molecular mechanism linked to cystic fibro-
sis and with the advantage of reducing the number of 
animals required. Starting from the previously acquired 
assumption that intratracheal instillation of hTNF-alpha 
1  week after delivery of the luciferase reporter DNA 
construct caused activation of bIL-8 in mice that could 
be easily detected and monitored by IVIS [20]; it was 
of interest to know if the same system could be applied 
in CF mice. To this end, CF mice were transiently 
transgenized with bIL-8-Luc.DNA construct, intratra-
cheally challenged with hTNF-alpha (1  µg/mouse) and 
compared with WT mice (Fig. 1) Luc expression driven 
by bIL-8 activation at 4  h after TNF-alpha challenge 
(Fig.  1e) revealed a significant increase of BLI in CF 
mice in comparison with WT animals (3.1 and 1.2 FOI, 
p  <  0.01) over baseline (untreated mice) (Fig.  1b, d, e). 
The BLI signal was still detectable without significant dif-
ferences at 24 h (Fig. 1b, d) in both CF and WT mice (1.5 
and 1.2, FOI respectively), while at 48 h the BLI signal was 
not detectable anymore. CF and WT mice intratrache-
ally treated with saline did not show any BLI signal either 
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at 4 h (Fig. 1a, c) or at later time points of observation. 
This preliminary set of experiments allowed us to select 
the optimal transfection conditions and to determine 
the right time of imaging acquisition. Although the gene 
delivery technology has been well established [20, 21, 23, 
24], every strain of mouse required their own transfec-
tion conditions and responded to stimuli in a different 
manner. C57Bl/6 mice have a black fur that is an obsta-
cle for optical imaging technologies, because black color 
quenched partially the light even if they were shaved in 
order to minimize the interference with BLI signal. In the 
next series of experiments, imaging has been performed 
only at 4 and 24  h because the BLI signal significantly 
decreased at 48 h. The same mice challenged with hTNF-
alpha, have been reutilized and intratracheally challenged 
with P. aeruginosa LPS (6.25  µg/mouse) after 2  weeks 
of wash-out. As shown in Fig. 2, both CF and WT mice 
responded to LPS reaching the maximum BLI signal 
between 4 and 24 h post-challenge. Interestingly, WT ani-
mals challenged with P. aeruginosa LPS showed a higher 
BLI signal compared to CF mice already at 4 h (3.2 and 
1.9 FOI respectively) over baseline (Fig.  2b, e, g). How-
ever only at 24 h, the BLI signal was significantly higher 
in CF compared to WT mice (6.7 and 2.1 FOI, p < 0.05) 
(Fig.  2b, e, g). No significant increases in the BLI signal 
was detected when CF and WT mice were intratrache-
ally treated with the culture medium (EMEM) (Fig.  2a, 
d). After imaging at 24 h, the same mice were sacrificed 
for BALFs collection and histological analysis. Right 
after BALF sampling, lungs were excised and imaging 
was performed. As clearly shown in ex vivo pictures the 
BLI signal was well localized in the lung and higher in CF 
compared to WT mice (Fig. 2c, f ), lending support to the 
positive correlation between in  vivo and ex  vivo imag-
ing. Formally, information collected by BLI (biolumi-
nescent signal in the lung higher in CF compared to WT 
mice) and from BALF (WBC and neutrophils counts in 
BALFs in both mouse strains) cannot directly compared 
and put “in contrast” to each other. (Fig. 2h). The lungs 
of CF and WT challenged with either EMEM (Fig. 2i, m) 
or P. aeruginosa LPS (Fig. 2l, n) were fixed in formalin for 
histological analysis after Giemsa staining. As expected, 
P. aeruginosa LPS-induced lung injury was character-
ized by neutrophils accumulation, alveolar wall thick-
ening and proteinaceous detritus accumulation in the 
alveolar space of the lungs of either CF or WT mice when 
compared to control mice treated with EMEM. Area of 
emphysema and a slight degree of fibrosis were detected 
within the lung parenchyma of WT and CF mice without 
any significant differences as regards the type and degree 
of histological damage (Fig. 2m, n). Eight in 23 cytokines 
evaluated in BALFs of WT and CF mice 24 h after stimu-
lation with P. aeruginosa LPS, resulted up-regulated when 
compared to the control animals (Fig. 3). IL-1β, IL-5, KC, 
IL-6, G-CSF, INFγ, MIP-1α, and TNF-α, are the major 
pro-inflammatory mediators in acute immune-response 
and they increased in the same manner in CF and WT 
LPS challenged mice. Their up-regulation resulted in full 
agreement between inflammatory cells infiltration and 
histological analysis (Fig. 2h, m, n).
Fig. 1 Representative in vivo images of WT and CF mice transiently transgenized with bIL-8-Luc and intratracheally challenged with hTNF-alpha 
(1 µg/mouse) and monitoring of bIL-8 activation by BLI. a, c: WT and CF mice treated with saline solution (control). b, d: WT and CF mice after 
intratracheal instillation with hTNF-alpha and monitoring of IL-8 activation at 4, 24 and 48 h by BLI. e: Time-course of IL-8-Luc activation in WT and 
CF mice. Results are reported as folds of increase (FOI) over baseline as mean ± SEM, n = 9 each group. Statistical differences were tested by one-
way ANOVA followed by Dunnett’s t post hoc test for group comparisons. *p < 0.05 and **p < 0.01
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In another series of experiments, WT and CF mice 
were challenged with the supernatant culture (10X) 
obtained from the P. aeruginosa clinical strain VR1 
[25]. As recently reported [25], this strain produces and 
releases in the culture medium a number of virulence 
factors, such as metalloproteases, pyocianine and pyo-
verdine, showing pro-inflammatory activity. Intratrache-
ally treatment with VR1Sn was able to activate bIL-8 in 
transiently transgenic CF and WT mice. (Fig.  4g). WT 
animals responded with an higher BLI signal at 4 h (1.6 
FOI) compared to CF mice, which revealed a very weak 
signal intensity at the same time point of observation 
(Fig. 4b, e, g). Nevertheless 24 h after challenge, BLI sig-
nal increased significantly in CF compared to WT mice 
(2.9 and 1.2 FOI, p < 0.05) (Fig. 2b, e, g). No significant 
increases in the BLI signal was detected when CF and 
WT mice when intratracheally treated with TSB (Fig. 2a, 
d). Either P. aeruginosa LPS or VR1Sn showed a similar 
behavior on bIL-8 activation. WT animals responded 
with max BLI signal at 4  h, indicating an early activa-
tion of the gene while, on the contrary, CF mice reveled a 
late response at 24 h. After in vivo imaging at 24 h, mice 
previously imaged were sacrificed, BALFs collected and 
lungs removed and subjected to histological analysis and 
BLI imaging as clearly shown in ex vivo pictures (Fig. 4c, 
f ). The BLI signal was higher in CF confirming the in vivo 
bioluminescence imaging data. Surprisingly and in con-
trast with BLI signal, VR1Sn induced an increase in total 
WBC and neutrophils in BALFs of CF and WT mice, 
but significant differences were not detectable (Fig.  4h). 
Lungs coming from TSB or VR1Sn challenged WT and 
CF mice were fixed in formalin and a Giemsa staining 
was performed. A widely diffused mononuclear cell infil-
trate characterized all the VR1Sn-challenged samples 
either from CF or WT mice as compared to control mice 
in which a normal parenchyma was presented (Fig.  4i, 
l). Histologically, the alveolar space and thicker alveolar 
septa were filled with acute phase inflammatory cells, 
Fig. 2 Representative in vivo images of WT and CF mice transiently transgenized with bIL-8-Luc and intratracheally treated with Pseudomonas LPS 
(6.25 µg/mouse). a, d: WT and CF mice treated with EMEM (control). b, e: WT and CF mice after intratracheal instillation with LPS and monitored 
IL-8 activation at 4 and 24 h by BLI. C, F: ex vivo images of IL-8 activation in lungs excised from WT and CF mice at 24 hs after LPS challenge. Panel 
G: Time-course of IL-8-luc activation in WT and CF mice. Results are reported as folds of increase (FOI) over baseline as mean ± SEM, n = 6 at each 
group. h: Cellular infiltration into the lung of WT and CF mice after intratracheal instillation with LPS at 24 h. Three mice were used for every time 
point and the experiment was replicated three times. Values are expressed as mean ± SEM of the three different experiments. Statistical differences 
were tested by one-way ANOVA followed by Dunnett’s t post hoc test for group comparisons. *p < 0.05 and **p < 0.01 WT and CF TSB vs WT and CF 
LPS group.  (I–n): Representative photomicrographs of Giemsa stained lung of WT and CF mice after intratracheal instillation with EMEM (I, L) and 
LPS (M, N) at 24 h. Magnification 40×
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including neutrophils, eosinophils, alveolar macrophages 
and lymphocytes. Within the alveolar space also pro-
teinaceous detritus were detected. However, the same 
type and severity of histological damage was observed in 
WT and CF mice (Fig. 4m, n). Up-regulation of the same 
set of cytokines after P. aeruginosa LPS and VR1 culture 
supernatant treatment was observed (Fig. 5).
Discussion
The animal model previously developed has been suc-
cessfully adapted to CFTR-deficient mice. After induc-
tion with human TNF-alpha and P. aeruginosa LPS, it 
was possible to detect BLI signal exactly from the thorax 
areas with higher signals in CF animals with respect to 
WT mice at 24 h after challenge. Bioluminescent signal 
was still detectable for as long as 48  h, although at this 
time point the signal decreased and it became difficult to 
appreciate the differences between the two types of mice. 
Further validation by challenging the mice with culture 
supernatants containing virulence factors released by a 
clinical strain of P. aeruginosa previously characterized 
[25]. Also in this case, statistically significant differ-
ences between WT and CF inflammatory responses were 
revealed with a stronger response of CF mice as com-
pared to WT animals at 24 h. Lung inflammatory mark-
ers, such as immune cells, cytokines and histology, were 
monitored in BALF after pro-inflammatory stimulation 
but they did not show significant differences between 
CF and WT mice. Although surprising at a first glance, 
we must consider that a differential degree of strain sen-
sitivity to pro-inflammatory stimuli has been reported 
[26]. Indeed, the same intratracheal challenge consist-
ing in VR1Sn (10X) was used in BALB/C mice and the 
absolute number of inflammatory cells recruited into the 
lung 24  h after treatment was much higher than in the 
C57Bl/6 mouse strain [25], supporting this interpreta-
tion. The reporter gene utilized relies on bIL-8 promoter, 
which responds mainly to NF-κB while additional master 
genes, like AP-1 (Fos/Jun), NFATs, and STATs, control 
the expression of several cytokines [27]. Such additional 
pathways can be activated in different mouse strains that 
might bypass the need of full NF-κB recruitment. In our 
Fig. 3 Cytokines quantification in BALFs. WT and CF mice, treated with either EMEM or LPS and sacrificed at 24 h. A panel of 23 cytokines was 
analysed using a Bio-Plex™ Cytokine Assay Kit (Bio-Rad Laboratories). Eight resulted up-regulated compared to the control animals: IL-1β, IL-5, KC, 
IL-6, G-CSF, INFγ, MIP-1α, and TNF-α Three mice were used for every time point and the experiment was replicated three times. Values are expressed 
as mean ± SEM. Statistical differences were tested by one-way ANOVA followed by Dunnett’s t post hoc test for group comparisons. *p < 0.05 and 
**p < 0.01
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specific case, being the C57Bl/6 mice congenic, the dif-
ferential response to agonists further highlight the criti-
cal role of CF background in controlling inflammatory 
response.
At the moment we have not an explanation to the fact 
that we detected a stronger BLI signal in CF mice as com-
pared to WT animals although the immune response, 
measured with classical BALF markers, was comparable 
in the two type of mice. However, this undoubtedly might 
constitute an advantage allowing the detection of CF-
specific differences in the inflammatory response also in 
those cases in which both WT and CF responded equally 
as regards cell recruitment, cytokines expression and his-
tological changes.
Despite the fact that CFTR-deficient mouse model is 
considered of limited interest in the field of cystic fibro-
sis as it does not reproduce and develop the full CF 
phenotype [28]. Our data support the notion that dif-
ferential responses in CFTR defective-mice may occur, a 
fact that is in line with the pro-inflammatory phenotypes 
recognized in humans.
Conclusions
Non-invasive imaging techniques are increasingly con-
sidered in biomedical research and can lead to impor-
tant insights on disease development on the same mouse 
model. In this study we combined in  vivo gene delivery 
technology and non-invasive bioluminescence imaging, 
creating a unique tool to consider CF mice as suitable 
models in testing anti-inflammatory drugs and in inves-
tigating the molecular mechanism linked to cystic fibrosis 
[4]. Moreover, the possibility to repetitively test a single 
set of CF animals longitudinally has several advantages as 
it reduces the number of animals to sacrifice and the costs 
Fig. 4 Representative in vivo images of WT and CF mice transiently transgenized with bIL-8-Luc intratracheally challenged with VR1 culture super-
natant (10X/mouse), and monitoring of bIL-8 activation by BLI. a, d: WT and CF mice after intratracheal instillation with TSB (control). Panel B, E: WT 
and CF mice after intratracheal instillation with VR1Sn and monitoring of IL-8 activation at 4 and 24 h by BLI. c, f: ex vivo images of IL-8 activation in 
lungs excised from WT and CF mice at 24 h. g: Time-course of IL-8-luc activation in WT and CF mice after challenge with intratracheal VR1Sn. Results 
are reported as FOI over baseline as mean ± SEM, n = 6 for each group. Panel H: Cellular infiltration into the lung of WT and CF mice after intratra-
cheal instillation with VR1Sn. VR1Sn-induced neutrophils and white blood cells (WBC) recruitment in the airways at 24 h. Three mice were used for 
every time point and the experiment was replicated three times. Values are expressed as mean ± SEM of the three different experiments. Statistical 
differences were tested by one-way ANOVA followed by Dunnett’s t post hoc test for group comparisons. *p < 0.05 and **p < 0.01 WT and CF TSB 
vs WT and CF VR1 group.  (i–n) : Representative micro-photographs Giemsa staining of lung of WT and CF mice after intratracheal instillation with 
TSB(I, L), and VR1Sn (M, N) at 24 h. Magnification 40×
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of housing and increases the data quality by lowering the 
intra animals variability, since each mouse represent its 
own control. This principle, applied to a CFTR-deficient 
murine model, will permit to study the activation of the 
inflammatory pathways in the CFTR defective lung in 
response to different agonists and to study/identify bac-
terial products with pro-inflammatory activity. Further-
more, the model might be used to evaluate, in an in vivo 
setting, the possible anti-inflammatory effect of drugs and 
therapeutic treatments in a cystic fibrosis background.
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Fig. 5 Cytokines quantification in BALFs. WT and CF mice, treated with either TSB or VR1Sn and sacrificed at 24 h. A panel of 23 cytokines was ana-
lysed using a Bio-Plex™ Cytokine Assay Kit (Bio-Rad Laboratories), and eight resulted up-regulated compared to the control animals: IL-1β, IL-5, KC, 
IL-6, G-CSF, INFγ, MIP-1α, and TNF-α Three mice were used for every time point and the experiment was replicated three times. Values are expressed 
as mean ± SEM. Statistical differences were tested by one-way ANOVA followed by Dunnett’s t post hoc test for group comparisons. *p < 0.05 and 
**p < 0.01
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